Skip to Content

Join the 'Benign Prostatic Hyperplasia (BPH)' group to help and get support from people like you.

Benign Prostatic Hyperplasia (BPH) News

Related terms: Benign Prostatic Enlargement, Benign Prostatic Hypertrophy (BPH), Enlarged prostate, Prostate, enlarged, BPH, Benign Prostatic Hypertrophy

New Prostate Technique May Help Men's Nighttime Urination

Posted 4 Apr 2016 by Drugs.com

MONDAY, April 4, 2016 – Waking often in the night to urinate is a common problem among men who have an enlarged prostate, but an innovative new treatment has shown some promise in easing the problem, researchers are reporting. The procedure, called prostatic artery embolization (PAE), involves placing microscopic spheres in the arteries that supply blood to the prostate gland to partially block the blood flow. Reducing blood flow to the prostate causes the gland to soften and shrink, said lead researcher Dr. Sandeep Bagla, an interventional radiologist at the Vascular Institute of Virginia, in Woodbridge. In their new study, Bagla and his colleagues show that PAE improves symptoms in men suffering from nocturia – waking up repeatedly during the night to urinate. "Their urinary symptoms bothered them considerably less, and their quality of life also showed marked improvement," Bagla ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Urinary Incontinence, Prostatitis, Urinary Retention, Primary Nocturnal Enuresis, Prostate Tumor - Benign

'Suicide Gene Therapy' Plus Radiation Fights Prostate Cancer: Study

Posted 14 Dec 2015 by Drugs.com

MONDAY, Dec. 14, 2015 – A combination of "suicide gene therapy" and radiation is highly effective in treating prostate cancer, researchers say. In this type of gene therapy, a patient's cancer cells are genetically modified so that they prompt the person's immune system to attack the cells, the Houston Methodist Hospital researchers explained. "We have created a vaccine with the patient's own cancer cells, a treatment that complements, and may even enhance, what we can achieve with traditional radiation and hormonal therapies," study senior author Dr. E. Brian Butler, chair of the department of radiation oncology, said in a hospital news release. The study included 62 patients who were divided into two groups. One group, who had cancer cells confined to the prostate, received radiation treatment. The second group, who had more aggressive prostate cancer, received both radiation and ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy, Genitourinary Surgical and Other Conditions, Prostate Tumor - Benign

Low-Risk Prostate Cancer Often Not Monitored Closely

Posted 4 Dec 2015 by Drugs.com

FRIDAY, Dec. 4, 2015 – Most men with low-risk prostate cancer who choose "watchful waiting" instead of aggressive treatment may not be followed as closely as they should be, a new study suggests. This puts them in danger of their cancer progressing or spreading undetected, the researchers warned. "This is really an important finding, because before patients and their doctors decide to pursue active surveillance as a management option for prostate cancer, both the physician and patient should agree on a follow-up schedule to closely monitor the cancer," study first author Dr. Karim Chamie, an assistant professor of urology at University of California, Los Angeles, said in a university news release. The study included almost 38,000 men who were diagnosed with prostate cancer between 2004 and 2007, and followed through 2009. Of the approximately 3,600 men who chose close monitoring ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Diagnosis and Investigation, Prostate Tumor - Benign

Relaxed Guidelines on PSA Testing Might Miss Aggressive Tumors: Study

Posted 22 Sep 2015 by Drugs.com

TUESDAY, Sept. 22, 2015 – Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening has dropped by 28 percent, the researchers report. "On the positive side, there is a lot of prostate cancer that we don't need to know about," said lead researcher Dr. Daniel Barocas, an assistant professor of urologic surgery at Vanderbilt University, in Nashville, Tenn. These are low-risk cancers that most men will not die of, and the treatment can be more harmful than the cancer, he explained. "To that extent, the guideline had a beneficial effect," Barocas said. "On the negative side, we seem to be missing intermediate and ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Diagnosis and Investigation, Prostate Tumor - Benign

Too Few Men With Low-Risk Prostate Cancers Get 'Watch and Wait' Approach

Posted 30 Jun 2015 by Drugs.com

TUESDAY, June 30, 2015 – A wide majority of U.S. men with low-risk prostate cancer are being treated for the disease even though "active surveillance" is an option, a new report finds. Active surveillance – or watchful waiting – is the careful monitoring of prostate cancer for progression of the cancer that would indicate a need for treatment. Men in the Northeast and on the West Coast were especially likely to have active surveillance rather than cancer treatment, potentially sparing them from complications associated with treatment. The study data was collected in 2010 and 2011, and a lot has changed since that time in regard to the popularity of active surveillance, experts noted. Active surveillance is "gaining acceptance among urologists and patients," said study co-author Dr. Hui Zhu, chief of urology at the Louis Stokes Cleveland VA Medical Center in Ohio. "Age-appropriate men ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Prostate Tumor - Benign

Treating Gum Disease Might Help Prostate Symptoms: Study

Posted 22 May 2015 by Drugs.com

FRIDAY, May 22, 2015 – Treating gum disease may help reduce symptoms of prostate inflammation, which can make urination difficult, a small study suggests. Previous research has shown a link between gum disease and prostate inflammation – called prostatitis. The study included 27 men, age 21 and older, who had prostatitis and moderate to severe gum disease. The men underwent treatment for gum disease and showed significant improvement in their gums within four to eight weeks, the study authors said. The men received no treatment for their prostatitis, but symptoms of the condition improved in 21 of 27 of them after their gum disease was treated, according to the study published recently in the journal Dentistry. "This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," corresponding author Dr. ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Gingivitis, Prostatitis, Periodontitis, Prostate Tumor - Benign

New Therapy May Shrink Enlarged Prostate With Fewer Side Effects: Study

Posted 24 Mar 2014 by Drugs.com

MONDAY, March 24, 2014 – A new noninvasive procedure may bring long-term relief from symptoms caused by an enlarged prostate, a new study suggests. As men age, the prostate gland grows larger and may begin to press on the urethra. Enlarged prostate affects more than half of men by age 60 and causes symptoms such as frequent urination, weak urine stream and a persistent feeling of having to urinate. Surgery is the standard treatment for the condition, but can cause complications such as sexual dysfunction and impotence, experts note. The new treatment is called prostate artery embolization. "Prostate artery embolization is a promising therapy that has been performed outside the United States to improve men's symptoms," explained Dr. Man Hon, chief of interventional radiology at Winthrop University Hospital in Mineola, N.Y. "This procedure works by closing the blood supply to the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

Blood Vessel Treatment Might Reduce Symptoms of Enlarged Prostate

Posted 22 Jan 2014 by Drugs.com

WEDNESDAY, Jan. 22, 2014 – A new nonsurgical treatment for enlarged prostate might help ease symptoms such as frequent urination at night, Brazilian researchers report. Enlarged prostate – formally known as benign prostate hyperplasia – affects most men as they age, including more than half by age 60 and 90 percent by age 85. Problems caused by enlarged prostate include frequent urination, weak urine stream and a constant feeling of having to urinate. The new treatment – called prostate artery embolization – shrinks the prostate by temporarily blocking blood flow to the arteries that feed it, the researchers said, and can be done using a local anesthetic. The findings were scheduled to be reported Wednesday at the International Symposium on Endovascular Therapy, in Miami. Doctors at the University of Sao Paolo said they have used prostate artery embolization to treat 120 patients ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

New Device Approved for Enlarged Prostate

Posted 16 Sep 2013 by Drugs.com

MONDAY, Sept. 16 – The UroLift system has been approved by the U.S. Food and Drug Administration to treat low or blocked urine flow in men aged 50 and older who have an enlarged prostate. The prostate is a walnut-sized gland that's right below the bladder in males. When the gland becomes enlarged, as tends to happen in older men, it can restrict the flow of urine. The new device, which helps prevent the prostate from pressing on the urethra, was evaluated in clinical studies involving 274 men between the ages of 49 and 86. Participants given the device reported fewer symptoms of enlarged prostate and a better quality of life, the FDA said. The most common adverse reactions included pain or burning during urination, blood in the urine and incomplete emptying of the bladder. The UroLift system is produced by NeoTract Inc., based in Pleasanton, Calif. More information To learn more about ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

18-Year Study Finds Drug Cut Prostate Cancer Risk

Posted 14 Aug 2013 by Drugs.com

WEDNESDAY, Aug. 14 – A drug used to treat enlarged prostate and male pattern baldness also reduces a man's risk of prostate cancer by nearly a third, according to a large new study. The findings on nearly 19,000 men also overturn earlier concerns that treatment with finasteride – the agent in the prostate drug Proscar and the hair-loss drug Propecia – might promote the development of more virulent prostate cancers in men who contract the disease, researchers said. Finasteride did not affect overall survival rates or survival rates after diagnosis with prostate cancer for men who did and did not receive the drug, said study lead author Dr. Ian Thompson, a urologist and professor at the University of Texas Health Science Center. "If indeed the more high-grade cancers in the men taking finasteride were real, we would expect to find a higher death rate," Thompson said. "The survival of ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Finasteride, Propecia, Proscar, Androgenetic Alopecia

New Procedure May Shrink Enlarged Prostate Without Surgery

Posted 15 Apr 2013 by Drugs.com

MONDAY, April 15 – Men who need treatment for an enlarged prostate may soon have a new nonsurgical option, a small, early study suggests. Called prostatic artery embolization (PAE), the technique uses a catheter threaded into an artery in the leg. The catheter is guided to the artery that supplies blood to the prostate. Then, tiny beads are injected into the artery, which temporarily block the blood supply to the prostate. The temporary loss of blood supply causes the prostate to shrink, relieving symptoms, according to study lead author Dr. Sandeep Bagla. What's more, the new treatment doesn't appear to have the same risk of serious complications, such as incontinence and impotence, that often accompany enlarged prostate treatment. "This is fantastic news for the average man with benign prostatic hyperplasia. Many men decline current treatments because of the risks. But, for the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Tumor - Benign

Drug Used to Prevent Prostate Cancer Won't Lower Quality of Life

Posted 12 Sep 2012 by Drugs.com

WEDNESDAY, Sept. 12 – Proscar (finasteride), a drug used to treat an enlarged prostate, does not reduce the quality of life of men who use it for a prolonged period of time, found a new study funded by the U.S. National Cancer Institute. Published Sept. 12 in the Journal of the National Cancer Institute, the research involved men aged 55 and older enrolled in a seven-year randomized clinical trial looking at the drug's possible use for prostate cancer prevention. Researchers from the Fred Hutchinson Cancer Research Center in Seattle, led by Carol Moinpour of the public health sciences division, examined three areas of patients' quality of life. Proscar did not significantly affect the men's physical functioning, mental health or vitality, according to a journal news release. Participants completed questionnaires three months before the study and six months after the study began. They ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Finasteride, Propecia, Proscar

Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk

Posted 22 May 2012 by Drugs.com

TUESDAY, May 22 – Certain gene variants linked to prostate cancer may make men more susceptible to lower urinary tract symptoms, according to a new study. On the other hand, a different gene variant might protect against those symptoms, the study found. Researchers from the Feinberg School of Medicine at Northwestern University in Chicago identified 38 genetic sequence variants linked to prostate cancer risk in nearly 2,000 healthy, white men enrolled in a prostate cancer screening study. The men completed questionnaires on the severity of their lower urinary tract symptoms, their age and whether they took medications used to treat enlarged prostate (benign prostatic hyperplasia). Four of the genetic variants were associated with severity of urinary tract symptoms, even after taking into account other genetic variations, age and medication use. The study was scheduled to be presented ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary Retention

Statins May Help Prevent Enlarged Prostate: Study

Posted 21 May 2012 by Drugs.com

MONDAY, May 21 – Statin drugs commonly used to lower cholesterol levels may also slow the unhealthy growth of the prostate in men with elevated blood levels of prostate-specific antigen, a new study finds. Prostate-specific antigen, or PSA, levels are often elevated due to cancer or other conditions involving the prostate, explained researchers from Duke University Medical Center in Durham, N.C. The study authors noted that their findings are significant because an enlarged prostate affects up to 90 percent of men older than 70 years and can lead to bladder or kidney damage. Many of these men may already be taking a statin, which include cholesterol-lowering drugs such as Crestor, Lipitor, Pravachol or Zocor. "Given that prostate enlargement is an important health problem in the United States and elsewhere, and will be a larger problem as the population ages, it's important to ... Read more

Related support groups: Lipitor, Simvastatin, Benign Prostatic Hyperplasia (BPH), Crestor, Atorvastatin, Pravastatin, Zocor, Lovastatin, Rosuvastatin, Pravachol, Livalo, Red Yeast Rice, Lescol, Lescol XL, Mevacor, Baycol, Fluvastatin, Altoprev, Pitavastatin, Cerivastatin

Baldness Drug May Cause Sexual Side Effects: FDA

Posted 12 Apr 2012 by Drugs.com

THURSDAY, April 12 – Two Merck & Co. drugs – one to treat hair loss in men, the other to treat an enlarged prostate gland – will get revised labels warning of potential sexual side effects that can last even after patients stop taking the drugs, the U.S. Food and Drug Administration said Thursday. The two drugs – Propecia to combat male pattern baldness, and Proscar, to treat enlarged prostates – share the same chemical compound, called finasteride. One dose of Propecia contains 1 milligram of finasteride; one dose of Proscar contains 5 milligrams. The new Propecia label will include a warning of "libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug," the FDA said in a news release. The Proscar label will include a warning about "decreased libido that continued after discontinuation of the drug," the agency said. The labels ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Finasteride, Propecia, Proscar, Androgenetic Alopecia

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Prostatitis, Prostate Tumor - Benign, Renal and Genitourinary Disorders

Related Drug Support Groups

Cialis, Flomax, tamsulosin, Avodart, finasteride, doxazosin, terazosin, prazosin, tadalafil, view more... Rapaflo, Cardura, alfuzosin, Jalyn, Proscar, saw palmetto, Uroxatral, Hytrin, dutasteride, silodosin, Cardura XL, nettles, Minipress, Prostate SR, Carduran, Doxadura, Cascor, dutasteride / tamsulosin